Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > ARYX > Summary

ARYx Therapeutics, Inc.
(ARYX)

2.81USD   Up0.31 (12.40%)   
On Nov 26
 ARYx Therapeutics, Inc. (NGM:ARYX) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Last Trade: 2.81USD
Trade Time:Nov 26
Change:Up0.31 (12.40%)
Prev Close:2.50
Open:2.51
Bid:2.03 x 1000
Ask:N/A
1y Target Est:6.38
Day's Range:2.51 - 2.90
52wk Range:1.30 - 6.32
Volume:65,479
Avg Vol (3m):75,424.2
Market Cap:77.52M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A%)
Add ARYX to Portfolio   Download Data

HEADLINES

 
•ARYX THERAPEUTICS, INC. Financials - EDGAR Online Financials  - Wed, Nov 18
•Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association - Business Wire  - Wed, Nov 18
•New Star Analyst Rankings for ARYx Therapeutics, Inc. - StarMine  - Sun, Nov 15
•ARYX THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report - EDGAR Online  - Fri, Nov 13
•Aryx Therapeutics reports $8.2M loss - bizjournals.com  - Thu, Nov 12
•Third Quarter 2009 Results and Earnings Call scheduled for 11:00 am ET today - Shareholder.com  - Thu, Nov 12
•ARYx Therapeutics Reports Third Quarter 2009 Results - Business Wire  - Thu, Nov 12
•Q3 2009 ARYx Therapeutics Earnings Release - Time Not Supplied - CCBN  - Thu, Nov 12
•ARYX THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E - EDGAR Online  - Thu, Nov 12
•ARYx Therapeutics Schedules Third Quarter 2009 Results Conference Call - Business Wire  - Thu, Nov 5
» More Headlines for ARYX...

ANALYST

 
EPS Est (next year) (Dec-09) :-1.11
EPS Est (in 2 years) (Dec-10) :-0.27
Avg Rec (current)*:1.3
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
ARYx Therapeutics, Inc., a biopharmaceutical company, focuses on developing a portfolio of product candidates designed to eliminate known safety issues associated with commercial drugs using its RetroMetabolic Drug Design technology.

» Full Company Profile